Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0LHTOB
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
PCM5B14-DCM
|
|||||
| Synonyms |
PCM5B14 DCM
Click to Show/Hide
|
|||||
| Drug Status |
Investigative
|
|||||
| Indication |
In total 4 Indication(s)
Breast cancer [ICD11:2C60-2C65]
Investigative
Colon cancer [ICD11:2B90]
Investigative
Lung cancer [ICD11:2C25]
Investigative
Pancreatic cancer [ICD11:2C10]
Investigative
|
|||||
| Drug-to-Antibody Ratio |
3.48
|
|||||
| Structure |
|
|||||
| Antibody Name |
H5B14
|
Antibody Info | ||||
| Antigen Name |
Macrophage-stimulating protein receptor (MST1R)
|
Antigen Info | ||||
| Payload Name |
Duocarmycin Sa
|
Payload Info | ||||
| Therapeutic Target |
Human Deoxyribonucleic acid (hDNA)
|
Target Info | ||||
| Linker Name |
Mc-PEG4-Val-Cit-PABC-DMAE
|
Linker Info | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.